| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
73,583,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,917,000 |
Avg
Vol: |
893,411 |
| 52
Week Range: |
$259.55 - $259.55 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Whitten Timothy G |
Sr Vice President |
• – – |
2005-04-29 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
5,216 |
|
- |
|
| Miller Richard A Md |
Pres, CEO & Director |
• • – |
2005-04-29 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
262,383 |
|
- |
|
| Renschler Markus Md |
VP, Oncology Clinical Dev. |
• – – |
2004-11-11 |
4 |
S |
$11.49 |
$483,190 |
D/D |
(42,000) |
1,394 |
|
- |
|
| Renschler Markus Md |
VP, Oncology Clinical Dev. |
• – – |
2004-11-11 |
4 |
OE |
$4.25 |
$182,607 |
D/D |
42,000 |
43,394 |
|
- |
|
| Whitten Timothy G |
Sr Vice President |
• – – |
2004-10-29 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
4,216 |
|
- |
|
| Miller Richard A Md |
Pres, CEO & Director |
• • – |
2004-10-29 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
261,383 |
|
- |
|
| Lea Leiv |
VP Fin & Admin & CFO |
• – – |
2004-10-29 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
4,893 |
|
- |
|
| Miller Richard A Md |
Pres, CEO & Director |
• • – |
2004-04-30 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
260,383 |
|
- |
|
| Lea Leiv |
VP Fin & Admin & CFO |
• – – |
2004-04-30 |
4 |
A |
$4.93 |
$3,338 |
D/D |
677 |
3,893 |
|
- |
|
| Whitten Timothy G |
Sr Vice President |
• – – |
2004-04-30 |
4 |
A |
$4.93 |
$4,930 |
D/D |
1,000 |
3,216 |
|
- |
|
335 Records found
|
|
Page 14 of 14 |
|
|
